ArticleOpen forum infectious diseases2023

Microbiota-Based Live Biotherapeutic RBX2660 for the Reduction of Recurrent

Glenn Tillotson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.